News
Microthrombi, necrosis seen in COVID-19 hearts on autopsy
February 3, 2021
A new autopsy series shows microthrombi and focal necrosis in hearts of patients who died of COVID-19. The findings support use of anticoagulation, but best dosing remains unclear, researchers say.
News
Arthritis drugs ‘impressive’ for severe COVID but not ‘magic cure’
January 15, 2021
U.S. and U.K. experts weigh in on research that compares monoclonal antibody therapies with usual care for people critically ill with COVID-19.
News
COVID-19 symptoms persist months after acute infection
January 14, 2021
Majority of previously hospitalized patients were experiencing fatigue or muscle weakness 6 months after discharge.
News
Overdiagnosis and overtreatment of COPD appears rampant
January 14, 2021
How frequently is chronic obstructive pulmonary disease (COPD) overdiagnosed and overtreated in the general population?
News
Eosinophilia-guided treatment cuts corticosteroid exposure in COPD exacerbations
January 12, 2021
Is eosinophilia-guided therapy in the setting of a chronic obstructive pulmonary disease (COPD) exacerbation a safe way to reduce total systemic steroid exposure?
News
Cloth masks provide inferior protection vs. medical masks, suggests evidence review
January 12, 2021
If cloth masks are used during PPE shortages, pairing them with plastic face shields may offer additional protection.
News
The top pediatric articles of 2019
December 22, 2020
The ten articles that had the most impact on pediatric hospital medicine, as presented at HM20 Virtual.
Opinion
Understanding messenger RNA and other SARS-CoV-2 vaccines
December 14, 2020
Technological advances make these new and revolutionary vaccines a reality.
News
A multicenter trial of vena cava filters in severely injured patients
December 9, 2020
Can early (within 72 hours) prophylactic placement of inferior vena cava filter decrease the risk of pulmonary embolism or death in severely injured patients?
News
COVID-19 and risk of clotting: ‘Be proactive about prevention’
December 8, 2020
"We believe a systematic way of addressing this risk is best, with every patient hospitalized with COVID-19 receiving some type of thromboprophylaxis," authors of a review article say.